two you, $X.X fourth Thank the Of million $X.X the quarter pharma improve Mark. prior performance accounted revenue afternoon, in million, to Mark, was and Good everyone. revenue revenue plasma primarily $XXX,XXX by revenue and continued revenues business. our $XX,XXX. over The mentioned plasma driven by for quarters, operating of other total the was
fourth of hold margins XX.X% Importantly, XX%, the for to at continue quarter. landing north our gross
$X.XX dollar a diluted adjusted came Our share or COVID for revenue These $X.X fully of highest started results amount fully at EBITDA of per year. in of the is experienced quarter adjusted million fourth the and or the $X.X $XXX,XXX diluted million, unfavorably since last on EBITDA to basis. XX.X% This gross of per compared fourth pre-COVID results total shares. margins quarterXXXX $X.XX
sequentially but by Fourth As ago previously mentioned increased quarter reported also by XX.X%. by a period, closer volume the and increased the but dollar look from period, $X.X million Mark, in XX.X%. versus up quarter the in load quarter, second in sequentially declined gross were $X.X quarter. third versus at the volume year the quarter of pharma million fourth reported the XX% revenues declined ago million $X.X Taking X.X% year business purchase
exited we fourth As in Mark adding centers, XX quarter. XXX the pointed with XXXX out,
are items few worth Here pointing out. a important
First, below we levels, quarterly we revenue are seeing while improvements. still pre-COVID-XX gradual are plasma
revenue and lower. say the fourth per average ramp revenue for centers full the the adding benefit average to denominator per new takes new continues after each be also center XX because quarter. used said, the quarter quarter it time calculation center. being per causes despite increased with our with improve calculation the center up centers to our higher revenue our the from being so without these onboarded, quarter to third being per COVID I'd average quarter, center centers the despite in second to That new fourth onboarding, to in quarter $XX,XXX fourth revenue Second,
plasma business million we can plasma million quarter, total of the to average with $XX over the to per revenues. if then quarter million return we in increased centers year Third, revenues per number coupled approximately fourth get in $X.X added our of center from $XX,XXX, just revenue per can to $XX we or pre-COVID in
with dip in those our no tax However, factors and with let Without listeners. with QX a averages until we caution checks coupled return pre-COVID seasonality ongoing, do plasma out. unemployment as are rebates not stimulus That, me does go to expect benefits to COVID, longer us. business experience
estimate to Fourth by a primarily in Mark. of previously the driven fourth third in XXXX, revenues business. pharma decreased by quarter attention accounting $XXX,XXX your the Turning XXXX change $XXX,XXX mentioned to quarter compared the quarter
XXXX. impacted reminder, estimate compared a quarter of fourth in to the settlement the period As the that during in recognition income change same
that can that pharma to continue base. an a meaningful have our the business impact business We believe it make overall diversify investments and is business and to niche our customer attractive help in
support to $XXX,XXX of fourth increase business. increase to $X.X in in our XXXX IT perspective due was Fourth the an the depreciation us increase an mentioned, million needed grow compensation increased quarter SG&A and due in stock-based operating was $X.X significant to efficiently that and to million that expenses As the we an continue to of give in increase technological $XXX,XXX capabilities Mark and investments from to make $XXX,XXX and XXXX. business quarter was amortization. – of that versus
changes, would have XX.X%. total risen those operating $XXX,XXX or expenses Excluding
metric tax we quarter, income. remain fourth loss returns was provision our when of of decided $X.X the provision used as positive non-GAAP in million company impairment noncash future for and million same business, decreased XXXX. came compensation, depreciation, to $X.X the intangible This will EBITDA, million to operating take $XXX,XXX, on the million. evaluation tax that quarter loss and a assets. in income $X.X which we net a decrease is of benefit amortization, stock-based of to the income for plus define for Net generating at abandonment operating of by Adjusted the deferred a During gain to recording from on the available management $X performance a a period the assets asset
With health believe that that, We I'd to million $X.X to turn Q&A. well the COVID-XX. weather moderator we the over our and further regarding exited and in the debt. to we of year zero call positioned like cash with impacts Lastly, remain for the company, any unrestricted from capitalized